Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001437749-19-011909)

Filing Details

Accession Number:: 0001437749-19-011909
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-06-13 06:03:42
Reporting Period:: 2019-06-10

Accepted Time:: 2019-06-13 06:03:42
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1389545	Novabay Pharmaceuticals Inc.	NBY	Pharmaceutical Preparations (2834)	680454536

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1664299	Mijia Wu	Suite 6C, Building 3, Youyou Century Plz No. 428 Yang Gao South Road Shanghai China		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2019-06-10	47,619	$2.03	0	No	4	S	Direct
Common Stock	Disposition	2019-06-11	15,873	$4.04	0	No	4	S	Indirect	Spouse

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Indirect	Spouse

Footnotes

On May 21, 2015, Mr. Wu and his spouse each purchased a warrant, which were both subsequently exercised on September 29, 2016 for 15,873 shares of Common Stock. Mr. Wu disclosed the exercise of his warrant on October 3, 2016 but not the exercise of his spouse's warrant, which he beneficially owned. Mr. Wu's spouse subsequently sold the 15,873 shares she owned on June 11, 2019.